| Pa Professional Health Services | |
|
50 West Main St Ste 704 Uniontown PA 15401 | |
| (724) 439-9698 | |
| (724) 439-9701 |
| Full Name | Pa Professional Health Services |
|---|---|
| Speciality | Psychiatry & Neurology |
| Location | 50 West Main St, Uniontown, Pennsylvania |
| Authorized Official Name and Position | Jamie Lee Snowdon-hibbs (PRESIDENT OWNER-DIRECTOR) |
| Authorized Official Contact | 7244399698 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Pa Professional Health Services 50 West Main St Ste 704 Uniontown PA 15401 Ph: (724) 439-9698 | Pa Professional Health Services 50 West Main St Ste 704 Uniontown PA 15401 Ph: (724) 439-9698 |
| NPI Number | 1326003815 |
|---|---|
| Provider Enumeration Date | 04/19/2006 |
| Last Update Date | 08/22/2020 |
| Medicare PECOS PAC ID | 2668379835 |
|---|---|
| Medicare Enrollment ID | O20031216000462 |
News Archive
Tracheal tumors can be surgically removed, but most are too large for the surgery to be successful by the time they are discovered. Therefore, new therapeutic options are needed. Even in patients with operable tumors, the proportion of complete tumor resection is less than 60%. This outcome would be greatly improved if a trachea substitute with similar anatomical, physiological and biomechanical properties of the patient's original trachea were available.
Concerned about relatively low COVID-19 vaccination rates among U.S. Blacks and Latinos, Glenn Flores, M.D., chair of pediatrics at the University of Miami Miller School of Medicine, is helping to guide a faith-based initiative addressing one of the nation's most pressing healthcare challenges.
Dietary factors have long been known to play a major role in the development of obesity. The global increasing prevalence of obesity suggests that there should be some common changes in diet worldwide.
Fenwal Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal a new 510(k) clearance for its Amicus® blood cell separator.
The most common primary brain cancer is glioblastoma, a highly aggressive and deadly form of tumor that kills about 95 percent of its victims within five years of diagnosis. Like other brain cancers, it is extremely difficult to treat because glioblastomas are usually deeply embedded within healthy brain tissue and therefore nearly impossible to safely access. Chemotherapy drugs cannot reach these tumors because a membrane between the bloodstream and brain tissue, called the blood-brain barrier, blocks them.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326003815 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 104100000X | Social Worker | (* (Not Available)) | Primary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | (* (Not Available)) | Primary |
| Provider Name | Brian W Eberts |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1144297532 PECOS PAC ID: 5496652604 Enrollment ID: I20031216000666 |
News Archive
Tracheal tumors can be surgically removed, but most are too large for the surgery to be successful by the time they are discovered. Therefore, new therapeutic options are needed. Even in patients with operable tumors, the proportion of complete tumor resection is less than 60%. This outcome would be greatly improved if a trachea substitute with similar anatomical, physiological and biomechanical properties of the patient's original trachea were available.
Concerned about relatively low COVID-19 vaccination rates among U.S. Blacks and Latinos, Glenn Flores, M.D., chair of pediatrics at the University of Miami Miller School of Medicine, is helping to guide a faith-based initiative addressing one of the nation's most pressing healthcare challenges.
Dietary factors have long been known to play a major role in the development of obesity. The global increasing prevalence of obesity suggests that there should be some common changes in diet worldwide.
Fenwal Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal a new 510(k) clearance for its Amicus® blood cell separator.
The most common primary brain cancer is glioblastoma, a highly aggressive and deadly form of tumor that kills about 95 percent of its victims within five years of diagnosis. Like other brain cancers, it is extremely difficult to treat because glioblastomas are usually deeply embedded within healthy brain tissue and therefore nearly impossible to safely access. Chemotherapy drugs cannot reach these tumors because a membrane between the bloodstream and brain tissue, called the blood-brain barrier, blocks them.
› Verified 4 days ago
| Provider Name | Dale B Fruman |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1144211400 PECOS PAC ID: 6002862265 Enrollment ID: I20050330000917 |
News Archive
Tracheal tumors can be surgically removed, but most are too large for the surgery to be successful by the time they are discovered. Therefore, new therapeutic options are needed. Even in patients with operable tumors, the proportion of complete tumor resection is less than 60%. This outcome would be greatly improved if a trachea substitute with similar anatomical, physiological and biomechanical properties of the patient's original trachea were available.
Concerned about relatively low COVID-19 vaccination rates among U.S. Blacks and Latinos, Glenn Flores, M.D., chair of pediatrics at the University of Miami Miller School of Medicine, is helping to guide a faith-based initiative addressing one of the nation's most pressing healthcare challenges.
Dietary factors have long been known to play a major role in the development of obesity. The global increasing prevalence of obesity suggests that there should be some common changes in diet worldwide.
Fenwal Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal a new 510(k) clearance for its Amicus® blood cell separator.
The most common primary brain cancer is glioblastoma, a highly aggressive and deadly form of tumor that kills about 95 percent of its victims within five years of diagnosis. Like other brain cancers, it is extremely difficult to treat because glioblastomas are usually deeply embedded within healthy brain tissue and therefore nearly impossible to safely access. Chemotherapy drugs cannot reach these tumors because a membrane between the bloodstream and brain tissue, called the blood-brain barrier, blocks them.
› Verified 4 days ago
| Provider Name | Stacey R Tesauro |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1134399322 PECOS PAC ID: 1153407473 Enrollment ID: I20080327000300 |
News Archive
Tracheal tumors can be surgically removed, but most are too large for the surgery to be successful by the time they are discovered. Therefore, new therapeutic options are needed. Even in patients with operable tumors, the proportion of complete tumor resection is less than 60%. This outcome would be greatly improved if a trachea substitute with similar anatomical, physiological and biomechanical properties of the patient's original trachea were available.
Concerned about relatively low COVID-19 vaccination rates among U.S. Blacks and Latinos, Glenn Flores, M.D., chair of pediatrics at the University of Miami Miller School of Medicine, is helping to guide a faith-based initiative addressing one of the nation's most pressing healthcare challenges.
Dietary factors have long been known to play a major role in the development of obesity. The global increasing prevalence of obesity suggests that there should be some common changes in diet worldwide.
Fenwal Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal a new 510(k) clearance for its Amicus® blood cell separator.
The most common primary brain cancer is glioblastoma, a highly aggressive and deadly form of tumor that kills about 95 percent of its victims within five years of diagnosis. Like other brain cancers, it is extremely difficult to treat because glioblastomas are usually deeply embedded within healthy brain tissue and therefore nearly impossible to safely access. Chemotherapy drugs cannot reach these tumors because a membrane between the bloodstream and brain tissue, called the blood-brain barrier, blocks them.
› Verified 4 days ago
| Provider Name | Jamie L Snowdon Hibbs |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1629180385 PECOS PAC ID: 6901703180 Enrollment ID: I20120607000474 |
News Archive
Tracheal tumors can be surgically removed, but most are too large for the surgery to be successful by the time they are discovered. Therefore, new therapeutic options are needed. Even in patients with operable tumors, the proportion of complete tumor resection is less than 60%. This outcome would be greatly improved if a trachea substitute with similar anatomical, physiological and biomechanical properties of the patient's original trachea were available.
Concerned about relatively low COVID-19 vaccination rates among U.S. Blacks and Latinos, Glenn Flores, M.D., chair of pediatrics at the University of Miami Miller School of Medicine, is helping to guide a faith-based initiative addressing one of the nation's most pressing healthcare challenges.
Dietary factors have long been known to play a major role in the development of obesity. The global increasing prevalence of obesity suggests that there should be some common changes in diet worldwide.
Fenwal Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal a new 510(k) clearance for its Amicus® blood cell separator.
The most common primary brain cancer is glioblastoma, a highly aggressive and deadly form of tumor that kills about 95 percent of its victims within five years of diagnosis. Like other brain cancers, it is extremely difficult to treat because glioblastomas are usually deeply embedded within healthy brain tissue and therefore nearly impossible to safely access. Chemotherapy drugs cannot reach these tumors because a membrane between the bloodstream and brain tissue, called the blood-brain barrier, blocks them.
› Verified 4 days ago
| Provider Name | Erica Lynn Grim |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1265981815 PECOS PAC ID: 5294159182 Enrollment ID: I20200724001417 |
News Archive
Tracheal tumors can be surgically removed, but most are too large for the surgery to be successful by the time they are discovered. Therefore, new therapeutic options are needed. Even in patients with operable tumors, the proportion of complete tumor resection is less than 60%. This outcome would be greatly improved if a trachea substitute with similar anatomical, physiological and biomechanical properties of the patient's original trachea were available.
Concerned about relatively low COVID-19 vaccination rates among U.S. Blacks and Latinos, Glenn Flores, M.D., chair of pediatrics at the University of Miami Miller School of Medicine, is helping to guide a faith-based initiative addressing one of the nation's most pressing healthcare challenges.
Dietary factors have long been known to play a major role in the development of obesity. The global increasing prevalence of obesity suggests that there should be some common changes in diet worldwide.
Fenwal Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal a new 510(k) clearance for its Amicus® blood cell separator.
The most common primary brain cancer is glioblastoma, a highly aggressive and deadly form of tumor that kills about 95 percent of its victims within five years of diagnosis. Like other brain cancers, it is extremely difficult to treat because glioblastomas are usually deeply embedded within healthy brain tissue and therefore nearly impossible to safely access. Chemotherapy drugs cannot reach these tumors because a membrane between the bloodstream and brain tissue, called the blood-brain barrier, blocks them.
› Verified 4 days ago
News Archive
Tracheal tumors can be surgically removed, but most are too large for the surgery to be successful by the time they are discovered. Therefore, new therapeutic options are needed. Even in patients with operable tumors, the proportion of complete tumor resection is less than 60%. This outcome would be greatly improved if a trachea substitute with similar anatomical, physiological and biomechanical properties of the patient's original trachea were available.
Concerned about relatively low COVID-19 vaccination rates among U.S. Blacks and Latinos, Glenn Flores, M.D., chair of pediatrics at the University of Miami Miller School of Medicine, is helping to guide a faith-based initiative addressing one of the nation's most pressing healthcare challenges.
Dietary factors have long been known to play a major role in the development of obesity. The global increasing prevalence of obesity suggests that there should be some common changes in diet worldwide.
Fenwal Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal a new 510(k) clearance for its Amicus® blood cell separator.
The most common primary brain cancer is glioblastoma, a highly aggressive and deadly form of tumor that kills about 95 percent of its victims within five years of diagnosis. Like other brain cancers, it is extremely difficult to treat because glioblastomas are usually deeply embedded within healthy brain tissue and therefore nearly impossible to safely access. Chemotherapy drugs cannot reach these tumors because a membrane between the bloodstream and brain tissue, called the blood-brain barrier, blocks them.
› Verified 4 days ago
Zubchevich Psychiatric Associates, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 7835 National Pike, Uniontown, PA 15401 Phone: 724-439-8050 | |
Momentum Couples & Family Therapy, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 315 Morgantown St, Suite 7000, Uniontown, PA 15401 Phone: 724-557-6598 Fax: 724-550-4160 | |
Tumeh Psychiatric Services, Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 30 Poplar Ln Uppr Level, Uniontown, PA 15401 Phone: 404-513-0326 | |
Chestnut Ridge Counseling Services Inc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 100 New Salem Rd, Suite 116, Uniontown, PA 15401 Phone: 724-437-0729 Fax: 724-437-2761 | |
Fayette Specialty Associates-neurology Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 205 Easy St, Suite 107, Uniontown, PA 15401 Phone: 724-438-1464 Fax: 724-438-1548 | |
George Heckman, Lpc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6 Ben Lomond St, Uniontown, PA 15401 Phone: 724-425-0223 Fax: 724-425-0331 | |
Stacey Renee Tesauro Inc. Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 50 West Main Street Suite 704, Uniontown, PA 15401 Phone: 724-439-9698 Fax: 724-439-9701 |